Intuitive Surgical, Inc. $ISRG is Sandler Capital Management's 10th Largest Position

Key Points

• Sandler Capital Management increased its stake in Intuitive Surgical by 19.9%, now owning 13,315 shares valued at approximately $6.6 million, making it their 10th largest holding.
• Several institutional investors significantly increased their holdings in Intuitive Surgical, with notable boosts of 614.3% by Chilton Capital Management and 300.0% by TD Capital Management.
• Intuitive Surgical reported earnings of $2.19 per share for the latest quarter, exceeding expectations, with a revenue of $2.44 billion, marking a 21.4% increase year-over-year.

Sandler Capital Management grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 19.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,315 shares of the medical equipment provider's stock after buying an additional 2,206 shares during the period. Intuitive Surgical accounts for 1.7% of Sandler Capital Management's investment portfolio, making the stock its 10th largest position. Sandler Capital Management's holdings in Intuitive Surgical were worth $6,595,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in ISRG. Chilton Capital Management LLC lifted its holdings in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 43 shares during the last quarter. Global Financial Private Client LLC raised its position in shares of Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after purchasing an additional 38 shares during the period. Elite Financial Inc. purchased a new stake in shares of Intuitive Surgical during the 1st quarter valued at approximately $26,000. LFA Lugano Financial Advisors SA bought a new position in shares of Intuitive Surgical in the first quarter worth $30,000. Finally, TD Capital Management LLC boosted its stake in Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock worth $30,000 after purchasing an additional 45 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Down 0.5%

Shares of NASDAQ:ISRG traded down $2.46 during midday trading on Tuesday, hitting $467.54. 1,488,500 shares of the stock traded hands, compared to its average volume of 2,061,235. The business's 50 day moving average is $491.12 and its two-hundred day moving average is $510.92. The stock has a market capitalization of $167.60 billion, a PE ratio of 65.21, a P/E/G ratio of 4.93 and a beta of 1.61. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the previous year, the business earned $1.78 EPS. Intuitive Surgical's revenue was up 21.4% compared to the same quarter last year. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 336 shares of the company's stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the completion of the transaction, the director directly owned 1,074 shares in the company, valued at approximately $504,898.14. This represents a 23.83% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 4,500 shares of the firm's stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares of the company's stock, valued at approximately $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock worth $21,716,492 over the last quarter. 0.70% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on ISRG shares. Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $615.00 target price on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Zacks Research cut Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. Deutsche Bank Aktiengesellschaft restated a "sell" rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. UBS Group increased their price target on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a research report on Wednesday, July 23rd. Finally, Truist Financial lifted their price target on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a research note on Wednesday, July 23rd. Thirteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $595.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.